comparemela.com
Home
Live Updates
Gilead Sciences Pauses Enrollment for Cancer Treatment in Solid Tumor Trials : comparemela.com
Gilead Sciences Pauses Enrollment for Cancer Treatment in Solid Tumor Trials
Gilead Sciences said on Thursday enrollments to test its cancer drug, magrolimab, on solid tumors had been paused globally, a week after the U.S. regulator put some studies...
Related Keywords
Bengaluru ,
Karnataka ,
India ,
Innovent Biologics ,
Pratik Jain ,
Gilead Sciences ,
Reuters ,
Drug Administration ,
Forty Seven Inc ,
Anild Silva ,
Breast Cancer ,
Alignant Breast Neoplasm ,
Breast Carcinoma ,
Cancer ,
Alignant Neoplasia ,
Arcinoma ,
Alignant Neoplasm ,
Leukemia Leukaemia Blood Cancer ,
Tumor ,
Blood ,
Breast ,
Mammary Gland ,
Chemotherapy ,
comparemela.com © 2020. All Rights Reserved.